Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Herombopag prophylaxis for chemotherapy-related thrombocytopenia in children with acute lymphoblastic leukemia
ChiCTR2400093681Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hetrombopag in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: Blood platelet count. Started Dec 2024; status: recruiting.
02
Drugs
hetrombopag
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on ChiCTR2400093681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093681.